Chiropractors in Cataumet, MA Accepting Medicare
1 Chiropractors found. Showing 1 - 1
 Cataumet Chiropractic Inc Chiropractor Medicare: Medicare Enrolled Practice Location: 1379 Rt 28a Unit B1, Cataumet, MA 02534 Phone: 508-392-9373 Fax: 508-392-9472 |
News Archive
Cancer patients should find ways to be physically active during and after treatment: New national guidelines
Cancer patients who've been told to rest and avoid exercise can - and should - find ways to be physically active both during and after treatment, according to new national guidelines. Kathryn Schmitz, PhD, MPH, an associate professor of Epidemiology and Biostatistics and a member of the Abramson Cancer Center at the University of Pennsylvania School of Medicine, will present these guidelines at an educational session at the 2010 meeting of the American Society of Clinical Oncology, aimed at making cancer exercise rehabilitation programs as common as those offered to people who have had heart attacks or undergone cardiac surgery.
Opinions: Harper and global health; Health workers in developing countries; Funding commitments; DDT, GMO use
Canadian Prime Minister Stephen Harper "can use the relatively intimate setting of the G8's Muskoka meeting to press for a renewal of the G8's commitment to better health for Africans, and help the developed world be truly accountable for its promises," the Globe and Mail writes in an editorial. "The G8's failure to fully fund the historic aid commitments to Africa it made at the 2005 Gleneagles summit" puts the future success of the developing world at risk, the editorial states.
IMI to provide University of California-Irvine Medical Center supplemental IONM services
Impulse Monitoring, Inc. (IMI), a leading provider of intraoperative neurophysiological monitoring (IONM) services to hospitals, today announced that it has signed an agreement with the University of California-Irvine Medical Center to provide supplemental IONM technologist and real-time physician oversight support services.
Eli Lilly presents early-stage data from several targeted cancer therapies at AACR 2014
Eli Lilly and Company will present early-stage data from several targeted cancer therapies – including bemaciclib "beh meh sye' klib" (LY2835219), its oral, cell-cycle inhibitor of CDK4/6 – that make up its diverse clinical oncology pipeline during the American Association for Cancer Research (AACR) Annual Meeting 2014 held in San Diego, Calif. from April 5 – 9.
› Verified 8 days ago